Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Dongduk Women’s University halts coeducation talks

    Dongduk Women’s University halts coeducation talks
  2. 2

    Defense ministry denies special treatment for BTS’ V amid phone use allegations

    Defense ministry denies special treatment for BTS’ V amid phone use allegations
  3. 3

    Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says

    Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
  4. 4

    OpenAI in talks with Samsung to power AI features, report says

    OpenAI in talks with Samsung to power AI features, report says
  5. 5

    Two jailed for forcing disabled teens into prostitution

    Two jailed for forcing disabled teens into prostitution
  1. 6

    South Korean military plans to launch new division for future warfare

    South Korean military plans to launch new division for future warfare
  2. 7

    Trump picks ex-N. Korea policy official as his principal deputy national security adviser

    Trump picks ex-N. Korea policy official as his principal deputy national security adviser
  3. 8

    Gold bars and cash bundles; authorities confiscate millions from tax dodgers

    Gold bars and cash bundles; authorities confiscate millions from tax dodgers
  4. 9

    Kia EV9 GT marks world debut at LA Motor Show

    Kia EV9 GT marks world debut at LA Motor Show
  5. 10

    Teen smoking, drinking decline, while mental health, dietary habits worsen

    Teen smoking, drinking decline, while mental health, dietary habits worsen
지나쌤

[Photo News] KDDF partners with MSD for new drug development

By Sohn Ji-young

Published : June 8, 2016 - 13:46

    • Link copied

Korea Drug Development Fund CEO Joo Sang-aun (left) and Mathai Mammen, senior vice president of cardiovascular diseases, metabolic diseases, immunology and oncology at U.S.-based pharmaceutical company Merck Sharp & Dohme signed a memorandum of understanding Tuesday at the 2016 BIO International Convention taking place in San Francisco. The two have agreed to launch a new joint research and development program geared at linking Korea’s new drug development capabilities with global pharmaceutical companies, the KDDF said. (KDDF) Korea Drug Development Fund CEO Joo Sang-aun (left) and Mathai Mammen, senior vice president of cardiovascular diseases, metabolic diseases, immunology and oncology at U.S.-based pharmaceutical company Merck Sharp & Dohme signed a memorandum of understanding Tuesday at the 2016 BIO International Convention taking place in San Francisco. The two have agreed to launch a new joint research and development program geared at linking Korea’s new drug development capabilities with global pharmaceutical companies, the KDDF said. (KDDF)

More from Headlines